2024

1. GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model

   Translational Neurodegeneration

2. Pharmacological inhibition of the integrated stress response accelerates disease progression in an amyotrophic lateral sclerosis mouse model

   British Journal of Pharmacology, Vol. 181, Núm. 3, pp. 495-508